News Releases - Achieve Life Sciences
HOME
ABOUT ACHIEVE
About Achieve
Management Team
Board of Directors
PRODUCTS
Cytisinicline
NEWS
Press Releases
Events
Blog
INVESTORS
CONTACT
HOME
ABOUT ACHIEVE
About Achieve
Senior Management
PRODUCTS
Cytisinicline
NEWS
INVESTORS
CONTACT
News Releases
Home
/
News Releases
Home
ivps4
2017-06-16T21:39:52+00:00
Investors Home
Corporate Governance
News Releases
Financial Information
SEC Filings
Events and Webcasts
Investor Contacts
Investor Alerts
NASDAQ: ACHV
NASDAQ: OGXI
News Releases
Investor Alerts
Year
All Years
2021
2020
2019
2018
2017
Keywords
Go
Advanced Search
Search
Search Headlines Only
From
To
Asset Types
Photos
Video
Audio
Documents
Events
Standard
Aug 8, 2019
/C O R R E C T I O N -- Achieve Life Sciences, Inc./
Jul 30, 2019
Achieve Life Sciences to Announce Second Quarter 2019 Financial Results and Host Conference Call and Webcast on August 8, 2019
Jul 23, 2019
Achieve Life Sciences Extends Collaboration with the National Institutes of Health to Advance the Development of Cytisinicline for Smoking Cessation
Jun 21, 2019
Achieve Life Sciences Announces Phase 2b ORCA-1 Trial Data Accepted for Oral Presentation at Society for Research on Nicotine & Tobacco Europe (SRNT-E) 19th Annual Conference
Jun 11, 2019
Achieve Life Sciences Announces Statistically Significant Improvement in Quit Rates for Simplified Cytisinicline Dosing Schedule in Phase 2b ORCA-1 Dose-Selection Trial
Show
5
10
25
50
100
per page
«
1
…
6
7
8
9
10
11
12
…
20
»
NASDAQ: ACHV
NASDAQ: OGXI
1dy
1mo
6mo
1yr
5yr
Stock Info
NASDAQ: ACHV
NASDAQ: OGXI
Go to Top